ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,728Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 780

$708K Total Retail Price of All Prescriptions

Rank: 162 out of 780

536 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 536 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 536 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 10,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 679 390 S3 1 1
LEVOTHYROXINE SODIUM 613 494 2 5
SIMVASTATIN 477 355 3 2
METFORMIN HCL 448 274 4 8
AMLODIPINE BESYLATE 444 385 5 4
OMEPRAZOLE 397 248 6 3
LISINOPRIL 333 211 7 6
ATORVASTATIN CALCIUM 328 250 8 12
ZOLPIDEM TARTRATE 306 236 9 17
NEXIUM 295 206 10 22
GABAPENTIN 294 216 11 13
CITALOPRAM HBR 284 228 12 23
PRAVASTATIN SODIUM 275 201 13 9
LOSARTAN POTASSIUM 261 196 14 18
FUROSEMIDE 245 176 15 7
PANTOPRAZOLE SODIUM 244 205 16 25
METOPROLOL SUCCINATE 206 179 17 20
HYDROCHLOROTHIAZIDE 204 142 18 10
METOPROLOL TARTRATE 184 168 19 19
CARVEDILOL 182 123 20 14
CYMBALTA 160 86 21 51
ALENDRONATE SODIUM 144 117 22 44
GLIMEPIRIDE 144 102 22 30
GLIPIZIDE 141 92 24 74
ATENOLOL 137 76 25 21
MELOXICAM 130 97 26 16
TRAMADOL HCL 128 85 27 15
SERTRALINE HCL 123 102 28 27
CLONIDINE HCL 120 68 29 28
TAMSULOSIN HCL 119 90 30 36
ESTRADIOL 118 73 R 31 122
ISOSORBIDE MONONITRATE ER 110 92 32 60
DONEPEZIL HCL 105 99 33 31
RANITIDINE HCL 105 44 33 39
ESCITALOPRAM OXALATE 102 66 35 61
POTASSIUM CHLORIDE 101 60 36 11
BENAZEPRIL HCL 100 80 37 59
TRAZODONE HCL 92 64 38 35
SPIRIVA 91 67 39 72
WARFARIN SODIUM 90 72 40 24
LOVASTATIN 89 78 41 47
FLUTICASONE PROPIONATE 87 44 42 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 54 43 26
ALLOPURINOL 84 79 44 29
AMITRIPTYLINE HCL 83 38 R 45 48
CYCLOBENZAPRINE HCL 79 30 R 46 42
ZETIA 77 43 47 94
FLUOXETINE HCL 75 29 48 65
TRIAMTERENE-HCTZ 74 72 49 37
CRESTOR 74 50 49 32
LOSARTAN-HYDROCHLOROTHIAZIDE 73 40 51 33
PREDNISONE 69 49 52 40
BYSTOLIC 69 59 52 118
ENALAPRIL MALEATE 68 24 54 64
METHOCARBAMOL 63 58 R 55 84
SYNTHROID 63 38 55 77
AZITHROMYCIN 63 45 55 38
RAMIPRIL 62 61 58 70
KLOR-CON M20 62 54 58 57
HYDRALAZINE HCL 61 61 60 54
ROPINIROLE HCL 61 55 60 87
MIRTAZAPINE 59 55 62 58
CIPROFLOXACIN HCL 58 41 63 49
LANTUS 57 33 64 71
PROAIR HFA 57 23 64 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 31 66 88
JANUVIA 56 31 66 85
PREMARIN 56 32 R 66 110
LYRICA 54 21 69 52
VENLAFAXINE HCL ER 52 31 70 117
AMOX TR-POTASSIUM CLAVULANATE 51 36 71 135
SINGULAIR 51 26 71 73
FOSINOPRIL SODIUM 50 25 73 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.